Healthcare
Vaso Corporation(VASO)
Live Price
Offline$0.19
+0.00% today
1Y Change
+62.00%
Window
Jun 23, 2025 โ May 29, 2026
- Market Cap
- $30.00M
- Revenue Growth
- +2.7%
- EPS Growth
- +64.8%
- Dividend Yield
- 0.0%
Coverage: 236 bars ยท Jun 23, 2025 โ May 29, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Vaso Corporation (VASO) is a Healthcare stock with a market cap of $30.00M and listed on OTC. The stock last traded around $0.19 and up 62.0% across the available one-year price window (Jun 23, 2025 โ May 29, 2026). Baseline metrics include revenue growth of +2.7%, EPS growth of +64.8%, a dividend yield of 0.0%. What stands out right now is revenue +2.7%, EPS +64.8%, free cash flow +356.7% with operating margin 2.0% and ROIC -4.0%. Valuation is more restrained than many high-expectation growth names at P/E 21.3 and price/sales 0.4. Stock Foundry combines VASO price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+2.7% vs +7.6% peer median
Operating Margin
Below sector median
+2.0% vs +19.4% peer median
P/E
Below sector median
21.3 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 13, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +2.7% and EPS at +64.8%, with operating margin around 2.0%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +10.0% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 13, 2026 | โ | -1.4% | +19.2% | โ |
2026 Mar 31, 2026 | โ | -2.0% | -3.6% | +3.4% |
2025 Nov 14, 2025 | โ | +10.7% | +14.5% | +37.3% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
VASO
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
VASO Max Drawdown
-18.40%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for VASO and SPY.
Company Overview
Vaso Corporation
Other OTC
Vaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally. The company operates through three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed diagnostic imaging applications, managed network infrastructure, managed network transport, and managed security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging capital equipment, GEHC service agreements, GEHC training, and GEHC and third-party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices. This segment offers Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for ECG and blood pressure; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation therapy systems that are used for non-invasive, outpatient treatment of ischemic heart disease. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was incorporated in 1987 and is headquartered in Plainview, New York.
- Leadership
- Jun Ma
- IPO Date
- Aug 18, 1995
- Employees
- 298
- Street Address
- 137 Commercial Street
- Mailing
- Plainview, NY, 11803
- Region
- Plainview, NY, US
- Reporting Currency
- USD
- Investor Line
- 516 997 4600
- Last Updated
- May 5, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 21.3
- EV/EBITDA
- โ
- Price/Sales
- 0.4
- Price/Book
- 1.1
Growth
- Revenue
- +2.7%
- EPS
- +64.8%
- Free Cash Flow
- +356.7%
Profitability
- Gross Margin
- 61.4%
- Operating Margin
- 2.0%
- Net Margin
- 1.8%
- ROE
- 5.7%
- ROIC
- -4.0%
Balance Sheet
- Debt/Equity
- 0.06
- Current Ratio
- 1.59
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.